The Director General of the Ghana Standards Authority, Prof. Alex Duodoo, has emphasised the need for vigilance as unapproved products continue to infiltrate the market. He said that despite ...

"FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said ...

The Town Council is tired of property owners changing construction plans after Palm Beach's design boards have approved them. To crack down on what officials say is a growing trend, council ...

CEBU, Philippines — It's just a week away before the year ends, and yet the proposed P17 billion annual budget for 2025 remains unapproved by the Cebu City Council, which could lead to a budget ...

Some of the company’s unapproved ad contents, listed by the Council, include: Bye-bye to Ulcer Pains for its EU Tea; With Lungfax, Smoking is Healthy, With Lungitax, It’s a Happy Smoker ...

The product, distributed under the brand Par Pharmaceutical, is identified as unapproved by the FDA and misbranded with potentially misleading labeling. The recall targets all batches within their ...

A Lilly spokesperson said anyone marketing or selling unapproved versions of tirzepatide must now stop and begin transitioning patients to FDA-approved medicines. The Alliance for Pharmacy ...

Diabetes can be managed with medication and lifestyle changes, but Facebook posts promising a treatment for the condition use altered footage of well-known news anchors promoting supplements that are ...

Distribution of handbills/door hangers or leaving unapproved items in the Halls is prohibited. 5. Materials may not be posted in any unauthorized location, including doors, light posts, trees, ...

The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides ...

Image credit: Shutterstock/ zimmytws. The US Food and Drug Administration (FDA) has issued warning letters to four companies selling unapproved glucagon-like peptide-1 receptor agonist (GLP-1RA) ...